SOPHiA GENETICS officer proposes 1,224-share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SOPHiA GENETICS SA officer Daan Guido Maria Van Well gave notice of a proposed sale of 1,224 common shares, with an approximate sale date of November 16, 2026. The notice lists aggregate market value of 10,049.04 for the proposed sale.
It also lists three recent sales as Rule 10b5-1 sales: 1,411 shares on November 9, 2026; 6,168 on October 5, 2026; and 6,168 on September 11, 2026. The plan adoption date is June 11, 2026. The shares proposed for sale were acquired from the issuer as restricted stock units on April 28, 2022.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent SOPH sales did Daan Guido Maria Van Well report under a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.